NYSE
CLB

Core Laboratories NV

Oil & Gas Equipment & Services
Energy

Prices are adjusted according to historical splits.

Core Laboratories NV Stock Price

Vitals

Today's Low:
$25.2
Today's High:
$26.4694
Open Price:
$25.94
52W Low:
$13.1722
52W High:
$31.3583
Prev. Close:
$25.52
Volume:
409197

Company Statistics

Market Cap.:
$1.11 billion
Book Value:
4.19
Revenue TTM:
$502.79 million
Operating Margin TTM:
9.7%
Gross Profit TTM:
$96.08 million
Profit Margin:
4.72%
Return on Assets TTM:
5.18%
Return on Equity TTM:
13.06%

Company Profile

Core Laboratories NV had its IPO on 1995-09-20 under the ticker symbol CLB.

The company operates in the Energy sector and Oil & Gas Equipment & Services industry. Core Laboratories NV has a staff strength of 3,600 employees.

Stock update

Shares of Core Laboratories NV opened at $25.94 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $25.2 - $26.47, and closed at $25.58.

This is a +0.24% increase from the previous day's closing price.

A total volume of 409,197 shares were traded at the close of the day’s session.

In the last one week, shares of Core Laboratories NV have increased by +2.65%.

Core Laboratories NV's Key Ratios

Core Laboratories NV has a market cap of $1.11 billion, indicating a price to book ratio of 5.057 and a price to sales ratio of 1.7985.

In the last 12-months Core Laboratories NV’s revenue was $502.79 million with a gross profit of $96.08 million and an EBITDA of $65.45 million. The EBITDA ratio measures Core Laboratories NV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Core Laboratories NV’s operating margin was 9.7% while its return on assets stood at 5.18% with a return of equity of 13.06%.

In Q1, Core Laboratories NV’s quarterly earnings growth was a positive 151.7% while revenue growth was a positive 11.3%.

Core Laboratories NV’s PE and PEG Ratio

Forward PE
19.084
Trailing PE
46.451
PEG
0.493

Its diluted EPS in the last 12-months stands at $0.51 per share while it has a forward price to earnings multiple of 19.084 and a PEG multiple of 0.493. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Core Laboratories NV’s profitability.

Core Laboratories NV stock is trading at a EV to sales ratio of 2.3091 and a EV to EBITDA ratio of 19.5382. Its price to sales ratio in the trailing 12-months stood at 1.7985.

Core Laboratories NV stock pays annual dividends of $0.04 per share, indicating a yield of 0.17% and a payout ratio of 5.8%.

Balance sheet and cash flow metrics

Total Assets
$593.62 million
Total Liabilities
$95.62 million
Operating Cash Flow
$-2038000.00
Capital Expenditure
$2.21 million
Dividend Payout Ratio
5.8%

Core Laboratories NV ended 2024 with $593.62 million in total assets and $0 in total liabilities. Its intangible assets were valued at $593.62 million while shareholder equity stood at $200.15 million.

Core Laboratories NV ended 2024 with $52.04 million in deferred long-term liabilities, $95.62 million in other current liabilities, 1194000.00 in common stock, $2.84 million in retained earnings and $99.45 million in goodwill. Its cash balance stood at $16.29 million and cash and short-term investments were $16.29 million. The company’s total short-term debt was $11,073,000 while long-term debt stood at $180.44 million.

Core Laboratories NV’s total current assets stands at $227.93 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $110.70 million compared to accounts payable of $38.37 million and inventory worth $67.34 million.

In 2024, Core Laboratories NV's operating cash flow was $-2038000.00 while its capital expenditure stood at $2.21 million.

Comparatively, Core Laboratories NV paid $0.06 in dividends in 2024.

Other key metrics

Current Trading Price
$25.58
52-Week High
$31.3583
52-Week Low
$13.1722
Analyst Target Price
$22.81

Core Laboratories NV stock is currently trading at $25.58 per share. It touched a 52-week high of $31.3583 and a 52-week low of $31.3583. Analysts tracking the stock have a 12-month average target price of $22.81.

Its 50-day moving average was $24.62 and 200-day moving average was $22.98 The short ratio stood at 11.29 indicating a short percent outstanding of 0%.

Around 66.1% of the company’s stock are held by insiders while 10635% are held by institutions.

Frequently Asked Questions About Core Laboratories NV

The stock symbol (also called stock or share ticker) of Core Laboratories NV is CLB

The IPO of Core Laboratories NV took place on 1995-09-20

Similar Industry Stocks (Oil & Gas Equipment & Services)

Last Price
Chg
Chg%
$51.25
2.4
+4.91%
$27.87
-0.04
-0.14%
$0.88
-0.02
-1.94%
$17.4
-0.1
-0.57%
$72.68
-3.4
-4.47%
$22.3
1.04
+4.89%
$31.1
-2.92
-8.58%
$732.65
-28.3
-3.72%
Inogen Inc (INGN)
$5.9
0.05
+0.85%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients’ reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, hydrogen storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. The company was founded in 1936 and is based in Houston, Texas.

Address

Van Heuven Goedhartlaan 7 B, Amstelveen, Netherlands, 1181 LE